1. Home
  2. FSI vs IMUX Comparison

FSI vs IMUX Comparison

Compare FSI & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flexible Solutions International Inc. (CDA)

FSI

Flexible Solutions International Inc. (CDA)

HOLD

Current Price

$6.10

Market Cap

74.3M

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$0.63

Market Cap

85.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSI
IMUX
Founded
1991
2016
Country
Canada
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.3M
85.8M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
FSI
IMUX
Price
$6.10
$0.63
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$6.00
AVG Volume (30 Days)
32.7K
1.7M
Earning Date
11-14-2025
02-14-2026
Dividend Yield
1.62%
N/A
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
$38,563,427.00
N/A
Revenue This Year
$7.49
N/A
Revenue Next Year
$53.12
N/A
P/E Ratio
$44.08
N/A
Revenue Growth
0.18
N/A
52 Week Low
$3.46
$0.51
52 Week High
$11.48
$1.39

Technical Indicators

Market Signals
Indicator
FSI
IMUX
Relative Strength Index (RSI) 43.09 48.52
Support Level $6.60 $0.64
Resistance Level $6.96 $0.71
Average True Range (ATR) 0.40 0.05
MACD -0.05 0.01
Stochastic Oscillator 40.85 57.76

Price Performance

Historical Comparison
FSI
IMUX

About FSI Flexible Solutions International Inc. (CDA)

Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: